| Field | Topic | | Scientists |
| Reprogramming and Development | Identification of transcription factors required for self-renewal of ES cells | | H. Schöler |
| Generation of oocytes from ES cells | | H. Schöler |
| Reprogramming by ES cell fusion | | H. Schöler |
| Nuclear transfer derived cloned mice | | H. Schöler; M. Boiani |
| Telomere maintenance in reproductive cloning and mammalian development | | K.L. Rudolph; H. Niemann |
| Nuclear transfer derived transgenic cattle and pigs | | H. Niemann |
| Isolation of foetal and adult stem cells | | H. Niemann |
| Expression of a Tetracycline sensitive system in transgenic pigs | | H. Niemann; W. Kues |
| Mesodermal differentiation of rhesus monkey ES cells | | K. Welte; U. Martin |
| Response of embryonic and adult haematopoietic stem cells to genetic programming | | C. Baum |
| Signal transducers in development | | M. Gaestel |
| Proteolytic pathways in cell cycle regulation | | N. Malek |
| Analysis of transcriptional control and cell communication during organogenesis | | A. Kispert; A. Gossler |
| Genetic causes of organ malformation | | A. Kispert |
| Cellular dedifferentiation of endothelium, is linked to activation and silencing of certain nuclear transcription factors: Implications for endothelial dysfunction and vascular biology | | J. Borlak |
| Neotendon formation in mesenchymal stem cells by manipulation of the Smad8 signalling pathway | | G. Gross; A. Hoffmann |
| Haemato-lymphopoiesis and endothelium | Genetic causes of bone marrow failure | | K. Welte; C. Klein |
| Cloning of and clinical long-term treatment with recombinant G-CSF | | K. Welte |
| Role of EPO in endothelial regeneration | | H. Haller |
| Identification of “stemness” genes by insertional mutagenesis | | C. Baum |
| Telomere shortening limits haematopoiesis during ageing | | K.L. Rudolph |
| Preclinical testing of telomerase therapies for liver regeneration | | K.L. Rudolph |
| Cancer risk factors during regenerative failure in end stage disease (cirrhosis) | | K.L. Rudolph |
| Identification of genes regulating dendritic cell differentiation | | C. Klein |
| Role of chemokine receptors in lymphocyte homing and migration | | R. Förster |
| Mechanisms of immune tolerance | | G. Behrens; E. Jaeckel |
| The nature of diversity and diversification of the human MHC | | R. Blasczyk |
| Regulating MHC expression | | R. Blasczyk; A. Seltsam |
| Efficient gene transfer to hematopoietic stem cells in primates | | P. A. Horn |
| In vivo selection of stem cells | | P. A. Horn |
| First use of proteomics in clinical allogeneic hematopoietic stem cell transplantation | | E. Weissinger; A. Ganser |
| Circulating endothelial cells as markers of endothelial damage in allogeneic stem cell transplantation | | H. Haller; A. Ganser |
| Heart | Fist controlled clinical study of cell therapy in myocardial infarction | | H. Drexler; A. Ganser; K. Wollert |
| First report on stem cell imaging after intracoronary transfer in patients with myocardial infarction | | H. Drexler; K. Wollert |
| Understanding of potential contribution of adult and embryonic stem cells in myocardial regeneration | | T. Kofidis; U. Martin |
| Generation and characterisation of functional cardiomyocytes from rhesus monkey ES-cells | | U. Martin |
| Investigation of immunologal aspects of allogeneic intramyocardial ES-cell transplantation | | T. Kofidis |
| In vivo application of engineered heart tissue based on ES-cell-derived cardiomyocytes | | T. Kofidis |
| First clinical transplantation of tissue engineered heart valves | | A. Haverich |
| Development an clinical application of biodegradable cardiovascular stents based on magnesium alloys | | A. Haverich |
| Gene expression in distinct regions of the heart | | J. Borlak |
| Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation | | A. Hilfiker; D. Hilfiker-Kleiner; H. Drexler |
| STAT3 is required for myocardial capillary growth, control of interstitial matrix deposition, and protection of the heart from ischemic injury | | H. Drexler; D. Hilfiker-Kleiner |
| Pivotal role of nitric oxide and oxidant stress for progenitor cell in vivo regenerative capacity | | U. Land-messer; H. Drexler |
| Worldwide largest clinical programme for lung transplantation | | A. Haverich |
| Worldwide first successful clinical use of an artificial lung (Novalung) as bridge to lung transplantation | | S. Fischer; A. Haverich |
| Pivotal role of proteases in lung fibrosis | | T. Welte |
| Demonstration of bone marrow-derived precursor cells in lung regeneration and fibrosis | | H. Kreipe |
| First report on essential function of vascular Notch Signaling in angiogenesis | | F. P. Limbourg |
| First report on essential function of Notch Signaling in postnatal arteriogenesis | | F. P. Limbourg |
| Liver/pancreas | Clinical cell therapy using hepatocytes, novel cell application strategies for the treatment of metabolic liver disease | | M. Ott; M. Manns |
| Regeneration in chronic hepatitis | | M. Manns |
| Preclinical testing of telomerase therapies for liver regeneration | | K.L. Rudolph |
| Cancer risk factors during regenerative failure in end stage disease (cirrhosis) | | K.L. Rudolph |
| Role of oxidative stress and cytokines in beta cell death | | S. Lenzen |
| Glucokinase glucose sensor function in insulin secretion | | S. Lenzen |
| Development of large scale mouse mutagenesis | | R. Balling |
| Human ES-cells: Assessment of culture related infection risks and contaminations | | U. Martin |
| Experimental models and tools | In vivo microscopy of cell migration and intercellular interactions | | M. Gunzer; D.J. Manstein |
| Quantitative and cell-specific assay to measure incorporation of donor cells into solid organs | | H. Kreipe |
| Innovative integrating and episomal vectors for permanent and reversible cell modification, including delivery of siRNA | | J. Bode; D. Wirth; H. Hauser; M. Scherr; M. Eder; C. Baum |
| Genetic instability in gene-modified cells, sencescence and cancer | | S. Schlegel berger |
| Protein engineering, structure & design | | D.J. Manstein |
| Epigenetic analysis in differentiation and cancer | | H. Kreipe |
| Imaging, structure & functional analysis of individual molecules/molecular complexes | | B. Brenner |
| Scaffold production and funtionalization, nanoengineering, laser technology | Production and functionalization of bioidentical, induced degradable biomatrices | | A. Kirschning; P. Behrens; C. Grothe; T. Scheper |
| Bioidentical scaffolds made from polysialic acid | | R. Gerardy-Schahn |
| Development of two-photon polymerization technique for the fabrication of arbitrary 3D structures | | B.N. Chichkov |
| New mask-less nonlinear lithography for high-quality surface patterning | | B.N. Chichkov |
| Surface nanostructuring using femtosecond laser pulses | | A. Ostendorf, B. Chichkov |
| Waveguide structuring with fs-lasers | | U. Morgner |
| Sub-µm ultrahigh resolution Optical Coherence Tomography | | U. Morgner |
| Application of lasers and ultrafast optics in laser medicine and biomedical engineering | | W. Ertmer |
| Application of ultrashort laser systems in clinical applications of medicine and cell biology | | H. Lubatschowski |
| Development of optical tools for subcellular manipulation and imaging of submicron structures in living cells. | | A. Heisterkamp |
| Generation of few-cycle-pulses | | U. Morgner |
| Generation of intense high rep rate laser pulses | | U. Morgner |